Epidemiology: Open Access
Enhance the FDA's Postmarketing Drug Surveillance System of Adverse Effects through the Electronic Healthcare Data
Abstract
Author(s): Xianglin L Du
Du XL (2012) Enhance the FDA’s Postmarketing Drug Surveillance System of Adverse Effects through the Electronic Healthcare Data. Epidemiol 2:e104.
